Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Hormone Replacement Therapy (HRT) is the administration of hormones for replenishing those patients whose natural hormones are declining in their body. For example, it is prescribed to patient with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones. During menopause, with the falling estrogen levels, hormone replacement therapy is considered to be the most effective treatment for menopause symptoms. .
The increasing incidences of hormonal imbalance disorders and coupled with elderly population are the primary drivers of this market. With various types of hormonal changes, the female body mostly gets affected by the natural process of aging, leading to abnormalities and diseases. According to the American Society for Reproductive Medicine, the menopause window in approach to the age group of 45 to 59, and average age for menopause is 51. Thus, adding to the demand in the global hormone replacement therapy market. As indicated by the American Congress of Obstetricians and Gynecologists, approximately 6,000 women reach menopause on a daily basis, in the country of the U.S. alone.
The report analyses the global hormone replacement therapy market based therapy, route of administration, disease and geography.
The various types of hormone replacement therapy are categorised into estrogen, human growth, thyroid and testosterone replacement therapy. The estrogen hormone replacement therapy is likely to observe the largest number of prescriptions as this therapy is used in women during post-menopause or hysterectomy and helps them maintain the hormonal balance.
Moreover, the hormone growth replacement therapy is likely to observe significant growth owing to the rising incidences of growth deficiencies, particularly in infants. According to WHO, an estimated 15 million babies are born preterm and this number is rising and approximately 85% of these infants are not fully developed. Thus, the demand of the HRT is increasing.
The hormone replacement therapy can be administrated through various routes such as oral, parenteral, and transdermal. Oral medication is the most common form of hormone replacement therapy. Examples are conjugated Estrogens (Premarin), estradiol (Estrace), and Estratab.
The hormone replacement therapy is used to treat various diseases such as menopause, hypothyroidism, male hypogonadism, growth hormone deficiency etc. The menopause segment is likely to account for the largest market share. Rapidly increasing population of geriatric women leads to increase in the number of women with menopausal symptoms. According to the United Nations World Population Aging Report -2017, women accounted for 54% share of the global population aged 60 years or above and 61% of that aged 80 years or above in 2017. The use of hormone replacement therapy alleviates menopausal symptoms and lead to a major improvement in quality of life for women with menopausal symptoms.
Based on geography, the global Hormone Replacement Therapy market is segmented into North America, Europe, Asia Pacific and Rest of the World. North America accounted for the largest market share owing to the growing baby boomer population, high health care expenditure, and large number of prescriptions of hormonal treatment products.
Key players in the global hormone replacement therapy market include Abbott Laboratories, Novartis AG, Pfizer Inc., Mylan Laboratories, Merck & Co., Novo Nordisk AS, Bayer AG, Eli Lilly and Company, Genentech, F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co. Inc., Allergan, Noven Pharmaceuticals, Orion Pharma, Therapeutics MD, Endo Pharmaceuticals Inc, and Teva Pharmaceutical Industries Ltd among others
The report analyses the global hormone replacement therapy market based therapy, route of administration, disease and geography. The various types of hormone replacement therapy are categorised into estrogen, human growth, thyroid and testosterone replacement therapy. The hormone replacement therapy can be administrated through various routes such as oral, parenteral, and transdermal. The hormone replacement therapy is used to treat various diseases such as menopause, hypothyroidism, male hypogonadism, growth hormone deficiency etc. Based on geography, the global Hormone Replacement Therapy market is segmented into North America, Europe, Asia Pacific and Rest of the World.
Key players in the global hormone replacement therapy market include Abbott Laboratories, Novartis AG, Pfizer Inc., Mylan Laboratories, Merck & Co., Novo Nordisk AS, Bayer AG, Eli Lilly and Company, Genentech, F. Hoffmann-La Roche, Hisamitsu Pharmaceutical Co. Inc., Allergan, Noven Pharmaceuticals, Orion Pharma, Therapeutics MD, Endo Pharmaceuticals Inc, and Teva Pharmaceutical Industries Ltd among others.
Why to buy this report:
